These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 18559268)
1. Optimization of taxane binding to microtubules: binding affinity dissection and incremental construction of a high-affinity analog of paclitaxel. Matesanz R; Barasoain I; Yang CG; Wang L; Li X; de Inés C; Coderch C; Gago F; Barbero JJ; Andreu JM; Fang WS; Díaz JF Chem Biol; 2008 Jun; 15(6):573-85. PubMed ID: 18559268 [TBL] [Abstract][Full Text] [Related]
2. Probing the pore drug binding site of microtubules with fluorescent taxanes: evidence of two binding poses. Barasoain I; García-Carril AM; Matesanz R; Maccari G; Trigili C; Mori M; Shi JZ; Fang WS; Andreu JM; Botta M; Díaz JF Chem Biol; 2010 Mar; 17(3):243-53. PubMed ID: 20338516 [TBL] [Abstract][Full Text] [Related]
8. Interaction of epothilone analogs with the paclitaxel binding site: relationship between binding affinity, microtubule stabilization, and cytotoxicity. Buey RM; Díaz JF; Andreu JM; O'Brate A; Giannakakou P; Nicolaou KC; Sasmal PK; Ritzén A; Namoto K Chem Biol; 2004 Feb; 11(2):225-36. PubMed ID: 15123284 [TBL] [Abstract][Full Text] [Related]
9. Effects of C7 substitutions in a high affinity microtubule-binding taxane on antitumor activity and drug transport. Xiao X; Wu J; Trigili C; Chen H; Chu JW; Zhao Y; Lu P; Sheng L; Li Y; Sharom FJ; Barasoain I; Diaz JF; Fang WS Bioorg Med Chem Lett; 2011 Aug; 21(16):4852-6. PubMed ID: 21764308 [TBL] [Abstract][Full Text] [Related]
10. Preclinical pharmacologic evaluation of MST-997, an orally active taxane with superior in vitro and in vivo efficacy in paclitaxel- and docetaxel-resistant tumor models. Sampath D; Greenberger LM; Beyer C; Hari M; Liu H; Baxter M; Yang S; Rios C; Discafani C Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3459-69. PubMed ID: 16740771 [TBL] [Abstract][Full Text] [Related]
13. Cyclostreptin and microtubules: is a low-affinity binding site required? Prussia AJ; Yang Y; Geballe MT; Snyder JP Chembiochem; 2010 Jan; 11(1):101-9. PubMed ID: 19946930 [TBL] [Abstract][Full Text] [Related]
14. Structural insight into the stabilization of microtubules by taxanes. Prota AE; Lucena-Agell D; Ma Y; Estevez-Gallego J; Li S; Bargsten K; Josa-Prado F; Altmann KH; Gaillard N; Kamimura S; Mühlethaler T; Gago F; Oliva MA; Steinmetz MO; Fang WS; Díaz JF Elife; 2023 Mar; 12():. PubMed ID: 36876916 [TBL] [Abstract][Full Text] [Related]
15. Microtubule active agents: beyond the taxane frontier. Morris PG; Fornier MN Clin Cancer Res; 2008 Nov; 14(22):7167-72. PubMed ID: 19010832 [TBL] [Abstract][Full Text] [Related]
16. Microtubule interactions with chemically diverse stabilizing agents: thermodynamics of binding to the paclitaxel site predicts cytotoxicity. Buey RM; Barasoain I; Jackson E; Meyer A; Giannakakou P; Paterson I; Mooberry S; Andreu JM; Díaz JF Chem Biol; 2005 Dec; 12(12):1269-79. PubMed ID: 16356844 [TBL] [Abstract][Full Text] [Related]
17. Site occupancy calibration of taxane pharmacology in live cells and tissues. Pineda JJ; Miller MA; Song Y; Kuhn H; Mikula H; Tallapragada N; Weissleder R; Mitchison TJ Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11406-E11414. PubMed ID: 30429313 [TBL] [Abstract][Full Text] [Related]
19. Designing and Testing of Novel Taxanes to Probe the Highly Complex Mechanisms by Which Taxanes Bind to Microtubules and Cause Cytotoxicity to Cancer Cells. St George M; Ayoub AT; Banerjee A; Churchill CD; Winter P; Klobukowski M; Cass CE; Ludueña RF; Tuszynski JA; Damaraju S PLoS One; 2015; 10(6):e0129168. PubMed ID: 26052950 [TBL] [Abstract][Full Text] [Related]
20. Fluorescent taxoids as probes of the microtubule cytoskeleton. Evangelio JA; Abal M; Barasoain I; Souto AA; Lillo MP; Acuña AU; Amat-Guerri F; Andreu JM Cell Motil Cytoskeleton; 1998; 39(1):73-90. PubMed ID: 9453715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]